Behbakht K - Search Results

1

Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel.

Breed C, Hicks DA, Webb PG, Galimanis CE, Bitler BG, Behbakht K, Baumgartner HK. Breed C, et al. Among authors: behbakht k. Mol Cancer Res. 2019 Mar;17(3):741-750. doi: 10.1158/1541-7786.MCR-18-0451. Epub 2019 Jan 3. Mol Cancer Res. 2019. PMID: 30606772 Free PMC article.

2

Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems.

Aroutcheva AA, Simoes JA, Behbakht K, Faro S. Aroutcheva AA, et al. Among authors: behbakht k. Clin Infect Dis. 2001 Oct 1;33(7):1022-7. doi: 10.1086/323030. Epub 2001 Sep 5. Clin Infect Dis. 2001. PMID: 11528575

3

Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.

Behbakht K, Qamar L, Aldridge CS, Coletta RD, Davidson SA, Thorburn A, Ford HL. Behbakht K, et al. Cancer Res. 2007 Apr 1;67(7):3036-42. doi: 10.1158/0008-5472.CAN-06-3755. Cancer Res. 2007. PMID: 17409410

4

Distinct TRAIL resistance mechanisms can be overcome by proteasome inhibition but not generally by synergizing agents.

Menke C, Bin L, Thorburn J, Behbakht K, Ford HL, Thorburn A. Menke C, et al. Among authors: behbakht k. Cancer Res. 2011 Mar 1;71(5):1883-92. doi: 10.1158/0008-5472.CAN-10-2252. Cancer Res. 2011. PMID: 21363923 Free PMC article.

5

Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer.

Corr BR, Finlay-Schultz J, Rosen RB, Qamar L, Post MD, Behbakht K, Spillman MA, Sartorius CA. Corr BR, et al. Among authors: behbakht k. Int J Gynecol Cancer. 2015 Nov;25(9):1565-73. doi: 10.1097/IGC.0000000000000553. Int J Gynecol Cancer. 2015. PMID: 26495758 Free PMC article.

6

Bevacizumab induced hypertension in gynecologic cancer: Does it resolve after completion of therapy?

Corr BR, Breed C, Sheeder J, Weisdack S, Behbakht K. Corr BR, et al. Among authors: behbakht k. Gynecol Oncol Rep. 2016 Jun 16;17:65-8. doi: 10.1016/j.gore.2016.06.002. eCollection 2016 Aug. Gynecol Oncol Rep. 2016. PMID: 27617286 Free PMC article.

7

Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration.

Hicks DA, Galimanis CE, Webb PG, Spillman MA, Behbakht K, Neville MC, Baumgartner HK. Hicks DA, et al. Among authors: behbakht k. BMC Cancer. 2016 Oct 11;16(1):788. doi: 10.1186/s12885-016-2799-7. BMC Cancer. 2016. PMID: 27724921 Free PMC article.

8

A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance.

Dimberg LY, Towers CG, Behbakht K, Hotz TJ, Kim J, Fosmire S, Porter CC, Tan AC, Thorburn A, Ford HL. Dimberg LY, et al. Among authors: behbakht k. Mol Cancer Res. 2017 Apr;15(4):382-394. doi: 10.1158/1541-7786.MCR-16-0234. Epub 2017 Jan 20. Mol Cancer Res. 2017. PMID: 28108622 Free PMC article.

9

A method for extracting and characterizing RNA from urine: For downstream PCR and RNAseq analysis.

Zhou K, Spillman MA, Behbakht K, Komatsu JM, Abrahante JE, Hicks D, Schotl B, Odean E, Jones KL, Graner MW, Bemis LT. Zhou K, et al. Among authors: behbakht k. Anal Biochem. 2017 Nov 1;536:8-15. doi: 10.1016/j.ab.2017.08.003. Epub 2017 Aug 10. Anal Biochem. 2017. PMID: 28803886 Free PMC article.

10

PARP inhibitors: Clinical utility and possibilities of overcoming resistance.

Bitler BG, Watson ZL, Wheeler LJ, Behbakht K. Bitler BG, et al. Among authors: behbakht k. Gynecol Oncol. 2017 Dec;147(3):695-704. doi: 10.1016/j.ygyno.2017.10.003. Epub 2017 Oct 14. Gynecol Oncol. 2017. PMID: 29037806 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters